Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon Systems

Hepatitis C virus (HCV), a member of the Flaviviridae family, affects approximately 3% of the world's population and is becoming the leading cause of liver disease in the world. Therefore, the development of novel or more effective treatment strategies to treat chronic HCV infection is urgently...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lin, Hui-Mei, Wang, Jing-Chyi, Hu, Han-Shu, Wu, Pei-Shan, Wang, Wen-Hung, Wu, Su-Ying, Yang, Chi-Chen, Yeh, Teng-Kuang, Hsu, Tsu-An, Jiaang, Weir-Torn, Chao, Yu-Sheng, Chern, Jyh-Haur, Yueh, Andrew
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2013
Pynciau:
Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553732/
https://ncbi.nlm.nih.gov/pubmed/23165461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01403-12
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg